The active substance in GONAL-f, follitropin alfa, is a copy of the natural hormone FSH.

Each mL of the solution contains 600 IU (equivalent to 44 micrograms) follitropin alfa.

In clinicaltrials, an increase of the ovarian sensitivity to follitropin alfa was shown when administered with lutropin alfa.

Each ml of the solution contains 600 IU of follitropin alfa*, (equivalent to 44 micrograms).

The active substance in GONAL-f, follitropin alfa, is a copy of the natural hormone FSH.

Pergoveris should not be given in the same injection with other medicines, except follitropin alfa.

In clinicaltrials, an increase of the ovarian sensitivity to follitropin alfa was shown when administered with lutropin alfa.

Pergoveris should not be given in the same injection with other medicines, except follitropin alfa.

Bemfola 150 IU/0.25 mL: Each cartridge contains 150 IU (equivalent to 11 micrograms) follitropin alfa in 0.25 mL solution.

Bemfola 75 IU/0.125 mL: Each cartridge contains 75 IU (equivalent to 5.5 micrograms) follitropin alfa in 0.125 mL solution.

Bemfola 225 IU/0.375 mL: Each cartridge contains 225 IU (equivalent to 16.5 micrograms) follitropin alfa in 0.375 mL solution.

For example, after two weeks of GnRH agonist treatment, 150 to 225 IU Bemfola is administered for 7 days.

This medicine contains the active substance follitropin alfa, which is almost identical to a natural hormone produced by your body called “follicle-stimulating hormone” (FSH).

Adherence to recommended MENOPUR dosage and regimen of administration, and careful monitoring of therapy will minimise the incidence of such events.

Pharmacokinetics: Following i.v. administration, follitropin alpha (rDNA origin) is distributed to the extracellular fluid space with an initial half-life around 2 hours and eliminated from the body with a terminal half-life of about 1 day.